pargyline has been researched along with Glial Cell Tumors in 4 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehndiratta, S | 1 |
| Qian, B | 1 |
| Chuang, JY | 1 |
| Liou, JP | 1 |
| Shih, JC | 1 |
| Sareddy, GR | 1 |
| Nair, BC | 1 |
| Krishnan, SK | 1 |
| Gonugunta, VK | 1 |
| Zhang, QG | 1 |
| Suzuki, T | 1 |
| Miyata, N | 1 |
| Brenner, AJ | 1 |
| Brann, DW | 1 |
| Vadlamudi, RK | 1 |
| Costa, MR | 1 |
| Breakefield, XO | 1 |
| Buckman, TD | 1 |
| Sutphin, MS | 1 |
| Mitrovic, B | 1 |
4 other studies available for pargyline and Glial Cell Tumors
| Article | Year |
|---|---|
Topics: Acetylation; Animals; Cell Line, Tumor; Cell Proliferation; Drug Design; Enzyme Inhibitors; Glioma; | 2022 |
KDM1 is a novel therapeutic target for the treatment of gliomas.
Topics: Animals; Apoptosis Regulatory Proteins; Benzamides; Blotting, Western; Brain Neoplasms; Cell Line, T | 2013 |
Electrophoretic analysis of 3H-pargyline-labeled monoamine oxidases A and B from human and rat cells.
Topics: Animals; Blood Platelets; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Glioma; Humans; Hydr | 1980 |
Oxidative stress in a clonal cell line of neuronal origin: effects of antioxidant enzyme modulation.
Topics: Animals; Brain; Carmustine; Catalase; Cell Fractionation; Cell Survival; Clone Cells; Cytosol; Gliom | 1993 |